Anika Therapeutics Inc
ANIK
$20.99+0.53%
End of day · as of Sep 11, 2026, 5:16 AM ET
Mkt cap
$161.34M
EV/Sales
0.92
P/E ratio
N/A
FY2025 Revenue
$112.82M
EPS (TTM)
$-0.27
Gross Margin (FY2025)
56.56%
Profit Margin (FY2025)
-9.64%
Beta
0.65
Div yield
N/A
Sector
Healthcare
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ANIK revenue for 2025-12-31 was $112.8M. Net income was -$10.9M. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. ANIK currently screens at market cap $161.3M.
Use this ANIK research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ANIK income, balance, and cash tables.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Anika Therapeutics Inc (ANIK) revenue for Dec 31, 2025 was $112.8M. Net income was -$10.9M. Statements: https://lician.com/financials/anik
Anika Therapeutics Inc (ANIK) market capitalization is $161.3M on the latest cached snapshot.
Anika Therapeutics Inc (ANIK) cached previous close $20.88; day range $20.58 – $20.99; volume 48,412. Session quote: https://lician.com/quote/anik
Anika Therapeutics Inc (ANIK) latest cached earnings event is "ANIK earnings" on Jul 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ANIK filing is 8-K · Jul 29, 2026. Filings: https://lician.com/sec/anik